Ian C Han1, Mongkol Tadarati1, Katia D Pacheco1, Adrienne W Scott2. 1. Retina Division, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland. 2. Retina Division, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland. Electronic address: ascott28@jhmi.edu.
Abstract
PURPOSE: To evaluate macular vascular flow abnormalities identified by optical coherence tomography angiography (OCT-A) in patients with various sickle cell genotypes. DESIGN: Prospective, observational case series. METHODS: This is a single-institution case series of adult patients with various sickle cell genotypes. All patients underwent macular OCT-A (Avanti RTVue XR). Images were analyzed qualitatively for areas of flow loss and quantitatively for measures of foveal avascular area, parafoveal flow, and vascular density. The findings were compared by sickle cell genotype and retinopathy stage and correlated to retinal thickness and visual acuity. RESULTS: OCT-A scans of 82 eyes from 46 patients (60.9% female, mean age 33.5 years) were included. Sickle cell genotypes included 27 patients with hemoglobin SS (58.7%), 14 SC (30.4%), 4 beta-thalassemia (8.7%), and 1 sickle trait (2.2%). Discrete areas of flow loss were noted in 37.8% (31/82) of eyes overall and were common in both SS (40.0%, 20/50 eyes) and SC (41.7%, 10/24 eyes). Flow loss was more extensive in the temporal and nasal parafoveal subfields of the deep plexus with sickle SC or proliferative retinopathy. Retinal thickness measurements correlated with vascular density of the fovea, parafovea, and temporal and superior subfields. Visual acuity correlated with foveal avascular zone area and parafoveal vascular density in the superficial and deep plexi. CONCLUSIONS: Areas of abnormal macular vascular flow are common in patients with various sickle cell genotypes. These areas may be seen at any retinopathy stage but may be more extensive with sickle SC or proliferative retinopathy.
PURPOSE: To evaluate macular vascular flow abnormalities identified by optical coherence tomography angiography (OCT-A) in patients with various sickle cell genotypes. DESIGN: Prospective, observational case series. METHODS: This is a single-institution case series of adult patients with various sickle cell genotypes. All patients underwent macular OCT-A (Avanti RTVue XR). Images were analyzed qualitatively for areas of flow loss and quantitatively for measures of foveal avascular area, parafoveal flow, and vascular density. The findings were compared by sickle cell genotype and retinopathy stage and correlated to retinal thickness and visual acuity. RESULTS:OCT-A scans of 82 eyes from 46 patients (60.9% female, mean age 33.5 years) were included. Sickle cell genotypes included 27 patients with hemoglobin SS (58.7%), 14 SC (30.4%), 4 beta-thalassemia (8.7%), and 1 sickle trait (2.2%). Discrete areas of flow loss were noted in 37.8% (31/82) of eyes overall and were common in both SS (40.0%, 20/50 eyes) and SC (41.7%, 10/24 eyes). Flow loss was more extensive in the temporal and nasal parafoveal subfields of the deep plexus with sickle SC or proliferative retinopathy. Retinal thickness measurements correlated with vascular density of the fovea, parafovea, and temporal and superior subfields. Visual acuity correlated with foveal avascular zone area and parafoveal vascular density in the superficial and deep plexi. CONCLUSIONS: Areas of abnormal macular vascular flow are common in patients with various sickle cell genotypes. These areas may be seen at any retinopathy stage but may be more extensive with sickle SC or proliferative retinopathy.
Authors: Davis B Zhou; Maria V Castanos; Alexander Pinhas; Peter Gillette; Justin V Migacz; Richard B Rosen; Jeffrey Glassberg; Toco Y P Chui Journal: Biomed Opt Express Date: 2021-04-21 Impact factor: 3.732
Authors: W A J Birkhoff; L van Manen; J Dijkstra; M L De Kam; J C van Meurs; A F Cohen Journal: Graefes Arch Clin Exp Ophthalmol Date: 2019-09-16 Impact factor: 3.117
Authors: Tin Yan Alvin Liu; Ian C Han; Morton F Goldberg; Marguerite O Linz; Connie J Chen; Adrienne W Scott Journal: JAMA Ophthalmol Date: 2018-05-01 Impact factor: 7.389
Authors: Laura Dell'Arti; Giulio Barteselli; Lorenzo Riva; Elisa Carini; Giovanna Graziadei; Eleonora Benatti; Alessandro Invernizzi; Maria D Cappellini; Francesco Viola Journal: PLoS One Date: 2018-03-01 Impact factor: 3.240
Authors: Giselle Lynch; Adrienne W Scott; Marguerite O Linz; Ian Han; Jorge S Andrade Romo; Rachel E Linderman; Joseph Carroll; Richard B Rosen; Toco Y Chui Journal: Br J Ophthalmol Date: 2019-07-23 Impact factor: 4.638
Authors: Tristan T Hormel; Yali Jia; Yifan Jian; Thomas S Hwang; Steven T Bailey; Mark E Pennesi; David J Wilson; John C Morrison; David Huang Journal: Prog Retin Eye Res Date: 2020-07-24 Impact factor: 21.198